by ASTCT Talks
In a cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks,...
by ASTCT Talks
In this episode of ASTCT Talks, host Dr. Corey Cutler, MD, from Dana-Farber Cancer Institute, is joined by Dr. Pooja Khandelwal, MD (Cincinnati Children’s Hospital), Dr. Ben...
by Alex Kadhim
This study uses social media insights to reveal the substantial physical, emotional, and financial burden experienced by patients and caregivers living with chronic GVHD in the United States....
by Alex Kadhim
This multinational MAGIC consortium study shows that early use of systemic corticosteroids for grade I acute GVHD does not improve survival outcomes and may increase risks such as...
by Alex Kadhim
In a nationwide, retrospective cohort study, researchers from St. Mary’s Hospital, Kurume, and a nationwide consortium of Japanese transplant centers have shown that mycophenolate mofetil...
by Alex Kadhim
A recent single-center retrospective study, published in Transplantation and Cellular Therapy, investigated post-transplant outcomes in patients with TP53-mutated or 17p-deleted myeloid...